CD40 signaling activated by Epstein-Barr virus promotes cell survival and proliferation in gastric carcinoma-derived human epithelial cells

Microbes and Infection

Volumn 11, Issue 3, 2009, Pages 429-433

  Imadome, Ken Ichi ^a   Shimizu, Norio ^b   Yajima, Misako ^a   Watanabe, Ken ^b   Nakamura, Hiroyuki ^a   Takeuchi, Hiroaki ^c   Fujiwara, Shigeyoshi ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b Medical Research Institute   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; CD40; CD40L; Epithelial cell; Epstein Barr virus; Proliferation

Indexed keywords

BETA ACTIN; CALCIUM IONOPHORE; CD40 ANTIGEN; CD40 LIGAND; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; HYBRID PROTEIN; IMMUNOGLOBULIN G; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; VIRUS CELL INTERACTION;

ANTIGENS, CD40; CD40 LIGAND; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS;

HUMAN HERPESVIRUS 4;

EID: 62649091638     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.01.007     Document Type: Article

References (20)

1. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 2575-2628
2. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., and Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335 (1990) 128-130
3. Kikuta H., Taguchi Y., Tomizawa K., Kojima K., Kawamura N., Ishizaka A., Sakiyama Y., Matsumoto S., Imai S., Kinoshita T., Koizumi S., Osato T., Kobayashi I., Hamada I., and Hirai K. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333 (1988) 455-457
4. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincot Williams & Wilkins, Philadelphia 2511-2574
5. Dolcetti R., and Masucci M.G. Epstein-Barr virus: induction and control of cell transformation. J. Cell Physiol. 196 (2003) 207-218
6. van Kooten C., and Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9 (1997) 330-337
7. Imadome K., Shirakata M., Shimizu N., Nonoyama S., and Yamanashi Y. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7836-7840
8. Imadome K., Shimizu N., Arai A., Miura O., Watanabe K., Nakamura H., Nonoyama S., Yamamoto K., and Fujiwara S. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. J. Infect. Dis. 192 (2005) 1340-1348
9. Barranco S.C., Townsend Jr. C.M., Casartelli C., Macik B.G., Burger N.L., Boerwinkle W.R., and Gourley W.K. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 43 (1983) 1703-1709
10. Nakatani H., Tahara E., Yoshida T., Sakamoto H., Suzuki T., Watanabe H., Sekiguchi M., Kaneko Y., Sakurai M., Terada M., and Sugimura T. Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn. J. Cancer Res. 77 (1986) 849-853
11. Sakurai Y., Hirohashi S., Shimosato Y., Kodaira S., and Abe O. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Cancer Res. 48 (1988) 4053-4058
12. Yoshiyama H., Imai S., Shimizu N., and Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 71 (1997) 5688-5691
13. R.a.C. Duke, JP, Wiley, New York, 1994.
14. Adler B., Schaadt E., Kempkes B., Zimber-Strobl U., Baier B., and Bornkamm G.W. Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 437-442
15. Vonderheide R.H. Prospect of targeting the CD40 pathway for cancer therapy. Clin. Cancer Res. 13 (2007) 1083-1088
16. Gallagher N.J., Eliopoulos A.G., Agathangelo A., Oates J., Crocker J., and Young L.S. CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion. Mol. Pathol. 55 (2002) 110-120
17. Davies C.C., Mason J., Wakelam M.J., Young L.S., and Eliopoulos A.G. Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells. J. Biol. Chem. 279 (2004) 1010-1019
18. Baxendale A.J., Dawson C.W., Stewart S.E., Mudaliar V., Reynolds G., Gordon J., Murray P.G., Young L.S., and Eliopoulos A.G. Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth. Oncogene 24 (2005) 7913-7923
19. Sbih-Lammali F., Clausse B., Ardila-Osorio H., Guerry R., Talbot M., Havouis S., Ferradini L., Bosq J., Tursz T., and Busson P. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation. Cancer Res. 59 (1999) 924-930
20. Yamaguchi H., Tanaka F., Sadanaga N., Ohta M., Inoue H., and Mori M. Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells. Int. J. Oncol. 23 (2003) 1697-1702